by Kevin Robb | Aug 22, 2024
Last month, the U.S. Food and Drug Administration (FDA) agreed to formally review a revised Biologics License Application (BLA) from Mesoblast for their mesenchymal stromal cell (MSC) product, remestemcel-L. The submission represents the third attempt by the company...
by Hamideh Emrani | Nov 9, 2017
Another interesting talk, on the first morning of the Canadian Till & McCulloch Meetings, was from Dr. Bruce Verchere who spoke about possible routes to prevent graft rejection in the case of human β-cell and islet cell transplants for diabetes through...
by Holly Wobma | Apr 9, 2013
“A Rat’s Past Lives, a Giraffe and Bull” depicts the interaction between the extracellular matrix and differentiated hematopoietic stem cells. Image by Elizabeth Cambridge from the Cells I See library . If you Google the term “stem cells”, you will...
by Paul Krzyzanowski | May 22, 2012
Many readers may already have heard of Health Canada’s approval of Osiris’ Prochymal, a mesenchymal stem cell treatment for severe cases of pediatric Graft versus Host Disease (GvHD), with plenty of coverage circulating around the web. GvHD is a disease where...
by David Kent | Apr 19, 2011
A few weeks back, The Guardian reported on a proposal by Japanese doctors and scientists that would see the blood cells of Japanese nuclear clean-up workers banked as a precaution against possible exposure to radiation during the clean-up of the Fukishima power plant....
Comments